Get the latest Science News and Discoveries
AACR: Novel immunotherapies show promise for patients with kidney cancer and for solid organ transplant recipients ... - EurekAlert
<p>Researchers from The University of Texas MD Anderson Cancer Center presented encouraging findings today from two clinical trials in a plenary session highlighting advances in novel immunotherapy approaches at the American Association for Cancer Research (AACR) Annual Meeting 2024. The studies describe the use of chimeric antigen receptor (CAR) T cell therapy in patients with advanced kidney cancer and an oncolytic immunotherapy for patients with skin cancer following organ transplants. Information on all MD Anderson AACR Annual Meeting content can be found at MDAnderson.org/AACR.</p>
None
Or read this on Eureka Alert